Agilent Technologies Inc (A)
139.19
+5.28
(+3.94%)
USD |
NYSE |
Apr 23, 16:00
139.44
+0.25
(+0.18%)
After-Hours: 20:00
Agilent Technologies Gross Profit (TTM): 3.405B for Jan. 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
January 31, 2024 | 3.405B |
October 31, 2023 | 3.465B |
July 31, 2023 | 3.562B |
April 30, 2023 | 3.843B |
January 31, 2023 | 3.78B |
October 31, 2022 | 3.722B |
July 31, 2022 | 3.61B |
April 30, 2022 | 3.523B |
January 31, 2022 | 3.479B |
October 31, 2021 | 3.407B |
July 31, 2021 | 3.295B |
April 30, 2021 | 3.112B |
January 31, 2021 | 2.952B |
October 31, 2020 | 2.837B |
July 31, 2020 | 2.786B |
April 30, 2020 | 2.809B |
January 31, 2020 | 2.821B |
October 31, 2019 | 2.805B |
July 31, 2019 | 2.776B |
April 30, 2019 | 2.743B |
January 31, 2019 | 2.717B |
October 31, 2018 | 2.68B |
July 31, 2018 | 2.609B |
April 30, 2018 | 2.546B |
January 31, 2018 | 2.495B |
Date | Value |
---|---|
October 31, 2017 | 2.399B |
July 31, 2017 | 2.35B |
April 30, 2017 | 2.296B |
January 31, 2017 | 2.234B |
October 31, 2016 | 2.197B |
July 31, 2016 | 2.144B |
April 30, 2016 | 2.115B |
January 31, 2016 | 2.065B |
October 31, 2015 | 2.041B |
July 31, 2015 | 1.985B |
April 30, 2015 | 1.974B |
January 31, 2015 | 1.979B |
October 31, 2014 | 1.976B |
July 31, 2014 | 777.00M |
April 30, 2014 | 1.131B |
January 31, 2014 | 1.537B |
October 31, 2013 | 1.907B |
July 31, 2013 | 3.549B |
April 30, 2013 | 3.583B |
January 31, 2013 | 3.61B |
October 31, 2012 | 3.604B |
July 31, 2012 | 3.603B |
April 30, 2012 | 3.605B |
January 31, 2012 | 3.587B |
October 31, 2011 | 3.529B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
2.743B
Minimum
Apr 2019
3.843B
Maximum
Apr 2023
3.237B
Average
3.35B
Median
Gross Profit (TTM) Benchmarks
Bio-Rad Laboratories Inc | 1.427B |
Revvity Inc | 1.540B |
Bruker Corp | 1.513B |
Azenta Inc | 250.79M |
Harvard Bioscience Inc | 66.07M |